IDEAYA Biosciences, Inc.
IDYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001676725
In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding IDEAYA Biosciences, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 117 | 128 | +11 |
| Shares | 46.0M | 45.6M | −381.7K (−0.8%) |
| Value | $835.0M | $625.4M | −$209.6M (−25.1%) |
New holders (22)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Oconnor LLC | 138,949 | $1.91M | 0.05% |
| Schonfeld Strategic Advisors LLC | 49,325 | $677.2K | 0.01% |
| HRT Financial LP | 42,537 | $584.0K | 0.01% |
| Dynamic Technology Lab Private Ltd | 40,026 | $549.0K | 0.05% |
| BIT Capital GmbH | 34,004 | $466.9K | 0.07% |
| Victory Capital Management Inc | 30,700 | $421.5K | 0.00% |
| Qube Research & Technologies Ltd | 28,193 | $387.1K | 0.00% |
| Marshall Wace, LLP | 27,903 | $383.1K | 0.00% |
| Ziegler Capital Management, LLC | 26,510 | $364.0K | 0.01% |
| Profund Advisors LLC | 24,060 | $330.3K | 0.02% |
| Jacobs Levy Equity Management, Inc | 22,432 | $308.0K | 0.00% |
| Gsa Capital Partners LLP | 16,621 | $228.0K | 0.02% |
| XTX Topco Ltd | 14,459 | $198.5K | 0.04% |
| Engineers Gate Manager LP | 13,739 | $188.6K | 0.01% |
| Ergoteles LLC | 12,731 | $174.8K | 0.01% |
| Point72 Middle East FZE | 8,239 | $113.1K | 0.01% |
| Public Employees Retirement System of Ohio | 4,250 | $59.0K | 0.00% |
| Tucker Asset Management LLC | 206 | $2.83K | 0.00% |
| TCI Wealth Advisors, Inc. | 204 | $2.80K | 0.00% |
| Quadrant Capital Group LLC | 189 | $2.60K | 0.00% |
| C M Bidwell & Associates Ltd | 125 | $1.72K | 0.00% |
| Simplex Trading, LLC | 2 | $0 | 0.00% |
Sold out (11)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Tekla Capital Management LLC | 133,185 | $2.42M |
| Ghisallo Capital Management LLC | 87,500 | $1.59M |
| Nordea Investment Management AB | 62,325 | $1.13M |
| UBS Asset Management Americas Inc | 32,072 | $582.7K |
| TD Asset Management Inc | 14,502 | $263.5K |
| Gyon Technologies Capital Management, LP | 8,721 | $158.5K |
| Quantbot Technologies LP | 3,792 | $68.9K |
| Lazard Asset Management LLC | 3,502 | $63.0K |
| High Net Worth Advisory Group LLC | 1,500 | $27.3K |
| Clearstead Advisors, LLC | 1,251 | $22.7K |
| Steward Partners Investment Advisory, LLC | 250 | $4.54K |